Cervilenz Inc. is dedicated to making a difference in the world of prematurity. The company was founded in anticipation of cervical length measurement becoming a routine test for all pregnant women to screen for preterm birth risk. That change in clinical practice is underway now given recent publication of new professional society guidelines recommending vaginal progesterone treatment for pregnant women with a prematurely short cervix – a treatment proven to reduce preterm birth by nearly 50% while also improving infant outcomes. This advance in preterm birth prevention created an acute need for a fast, accurate, and inexpensive way to measure cervical length to identify patients for life-saving treatment. The innovative CerviLenz® device is designed for immediate, reliable cervical length screening during a routine prenatal visit in any healthcare setting.
Cervilenz Inc. was founded 2008 by Michael Ross, MD, MPH, Rosalyn Baxter-Jones, MD, and Dean Koch. Cervilenz Inc. is headquartered in the beautiful village of Chagrin Falls, a suburb of Cleveland, Ohio. CerviLenz was designed and is manufactured in Ohio. The CerviLenz device is cleared for sale in the U.S. and has its CE Mark and ISO 13485 Certification for international distribution.